• COPD Move
  • CRD Closing banner
  • Banner Child

    Putting you at the centre of all decisions affecting your health

  • Banner map

    30% of the European population lives with allergies, asthma and COPD

  • Banner hands

    Because breathing is taken for granted, we work for better recognition of chronic respiratory diseases

Our funding partners

EFA operates with funding from membership fees, public EU funding, private unrestricted core-funding and project funding from corporate sources and donations that are disclosed every year. EFA ensures that all forms of funding are open and transparent, ensuring accountability to its sponsors and partners. EFA has a Code of Ethics and Conduct and retains a sustainable partnership with industry to ensure its integrity when receiving funding from corporate sources.

 

Our Annual Report

The Annual Report, including audited financial accounts and overall budget for the next year is approved by the Annual General Meeting of Members.

Here are the reports from 20162015201420132012201120102009200820072006 and 2005.

 

2016 Annual Accounts

EFA thanks sincerily our funding partners who have made our work in 2016 possible:

Sustainable partnership with industry

 

- Operating programme sustainability

 

Air Liquide Sante International 

30.000,00

ALK Abello 

30.000,00

Astra Zeneca

30.000,00

Boehringer Ingelheim International 

30.000,00

Chiesi (donation)

5.000,00

GSK 

30.000,00

LindeGas

4.500,00

Novartis 

30.000,00

Roche

30.000,00

Sanofi

30.000,00

SIG Air Handling

15.000,00

Stallergenes

30.000,00

TEVA

30.000,00

- Project programme sustainability

 
EFA Asthma Project
 
Astra Zeneca 19.000,00
GSK 19.000,00
Novartis  19.000,00
TEVA 19.000,00
EFA Capacity Building Project
 

Boehringer Ingelheim International 

28.000,00

TEVA

30.000,00
Interest Group EP
 
ALB Abello 8.000,00
Novartis 8.000,00
CRD Campaign
 
Novartis  30.000,00

 

EFA funding sources for 2016